What Groupe Lépine does

Groupe Lépine is a privately-held French medical device manufacturer founded in 1714 and headquartered in Genay, France, with operations spanning 7 industrial sites and 9 commercial subsidiaries across Europe, North Africa, and South America. The company employs more than 450 people and serves hospitals, clinics, and orthopedic surgeons through both direct sales subsidiaries and a distributor network covering over 30 countries.

The company's core product portfolio is centered on orthopedic implants and immobilization devices. It manufactures a comprehensive range of prostheses covering hip (INTEGRA, EXEL R, TRENDHIP, PAVI, TARGOS), knee (KNEO, UNI GALICA, ROTAX), shoulder (ARAMIS family), and extremities (MAIA, INCA, COBRA), supplemented by osteosynthesis products (VISIOFIX plates and screws) and biomaterials (PHOENIX DBM demineralized bone allograft). It also produces a full line of CE-marked upper-limb, lower-limb, cervical, and trunk splints and orthoses. Manufacturing is fully vertically integrated through in-house design, 3D prototyping, forging (Orthez site producing 25,000+ femoral stems annually), precision casting (German foundry for acetabular cups and knee components acquired in 2016), machining, hydroxyapatite coating (in-house since the 2002 plasma torch acquisition), and ceramic component production. Proprietary technology differentiators include dual porous titanium + hydroxyapatite coating for osseointegration and alumina ceramic femoral heads and inserts.

Groupe Lépine operates a sales-led, business-to-business model targeting healthcare professionals. Revenue is generated through three streams: (1) hardware sales of orthopedic prostheses to hospitals and clinics, (2) hardware sales of splints and immobilization products, and (3) instrumentation kits with associated service fees for delivery, returns, and replacements. Pricing for splints ranges from €6.80 to €99.00 HT, while prosthesis pricing is available only through validated professional accounts (SIRET registration required). The company reaches customers through direct field sales via its 9 subsidiaries, a distributor network in 30+ countries, a gated professional e-commerce portal, participation in major European orthopedic congresses (FESSH, SOO, SFCR, SECEC, SOFCOT, SFA), and the Lépine Plus surgeon training platform. The company is controlled by Patrick Pfaifer, who acquired the family business in 1988 and formed the current Group structure in 1991.

Name

Groupe Lépine

Legal name

Lépine

Website

https://groupe-lepine.com

Company type

Private

Founded year

1714

Operating status

Operating

Headcount range

251–500 employees

Short description

Groupe Lépine is a privately-held French orthopedic medical device manufacturer, founded in 1714, producing hip, knee, shoulder, and extremity prostheses plus splints and osteosynthesis implants. It serves hospitals, clinics, and surgeons across Europe, North Africa, and South America through 9 wholly-owned subsidiaries and a 30+ country distributor network.

Ownership category

akta.pro rank

Headquarters

HQ city

Genay

HQ country

France

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Orthopedic Prostheses Sales: Sale of medical devices including hip, knee, shoulder, and extremity prostheses to hospitals and clinics through direct sales and distribution network.
2. Splints and Immobilization Products: Sale of orthopaedic splints for various body parts including neck, upper limb, trunk, and lower limb, as well as neonatal and emergency immobilization products.
3. Instrumentation and Kits: Provision of surgical kits and instrumentation to healthcare facilities, with loan terms and associated service fees for delivery, return, and replacement.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Groupe Lépine designs, manufactures, and distributes orthopedic medical devices, including joint replacement prostheses (hip, knee, shoulder, and extremities), osteosynthesis implants, biomaterials for bone regeneration, and a comprehensive range of orthopedic splints and orthoses. The company operates its own end-to-end production chain across 7 industrial sites in France and Germany, selling directly to hospitals, clinics, and healthcare professionals through 9 commercial subsidiaries and a global distributor network.

Product overview

Groupe Lépine is a French family-owned medical devices company founded in 1714, specializing in orthopedic implants and immobilization devices. The company operates a unified portfolio centered on four main pillars: (1) Joint replacement prostheses for hip, knee, shoulder, and small joints (MAIA, INCA, COBRA); (2) Biomaterials for bone regeneration; (3) Osteosynthesis implants including plates and screws; and (4) A comprehensive range of splints and orthoses for upper limb, lower limb, cervical, and trunk immobilization. All splints are CE-certified and manufactured in-house at their Lyonnais and Roannais facilities, with over 450 employees across 7 industrial sites. The company distributes through 9 commercial subsidiaries worldwide and via partner distributors in over 30 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Lépine Plus: Training platform and personalized course offering for healthcare professionals.

Products and services

• Hip Prostheses (INTEGRA, EXEL R, TRENDHIP, PAVI, TARGOS) Complete range of hip prostheses including cemented and non-cemented femoral stems, acetabular cups, and femoral heads in chrome cobalt, stainless steel, and alumina ceramic for hip replacement surgery.
• Knee Prostheses (KNEO, UNI GALICA, ROTAX) Full portfolio of knee replacement solutions including posterior stabilized fixed-bearing knee prosthesis (KNEO), unicondylar knee prosthesis (UNI GALICA), and rotating hinge knee prosthesis (ROTAX).
• Shoulder Prostheses (ARAMIS, ARAMIS-S, ARAMIS-T, ARAMIS-R)

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core.

• Lépine ColombiacoreChannel Partner/ Reseller/ Distributor · 1 January 2018Commercial subsidiary established in Colombia in 2018, expanding presence in South America from Bogotá.
• Lépine DeutschlandcoreChannel Partner/ Reseller/ Distributor · 1 January 2016Commercial subsidiary and precision foundry established in Germany in 2016, acquired to internalize complex geometry prosthesis component manufacturing.
• German Precision FoundrycoreStrategic or Co-development Partner · 1 January 2016Precision foundry acquired in Germany for internalizing complex geometry prosthesis components including acetabular cups and knee prosthesis components.
• Lépine ItaliacoreChannel Partner/ Reseller/ Distributor · 1 January 2012Commercial subsidiary established in Italy in 2012, operating from Segrate (Milano).
• Lépine IbericacoreChannel Partner/ Reseller/ Distributor · 1 January 2008First commercial subsidiary established in Spain in 2008, later expanding to additional Iberian markets under Lépine Ibérica.
• Lépine MaroccoreChannel Partner/ Reseller/ Distributor · 1 January 2008Commercial subsidiary established in Morocco in 2008 as part of North African expansion.
• Lépine AlgériecoreChannel Partner/ Reseller/ Distributor · 1 January 2008Commercial subsidiary established in Algeria in 2008 as part of North African expansion.
• Sanortho (Orthez)coreStrategic or Co-development Partner · 1 January 2005Manufacturing facility acquired in Orthez, France, for forging operations. Produces over 25,000 femoral stems annually and integrates femoral head development and production since 2013.

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Corin: UK-headquartered orthopedic implant manufacturer with similar mid-tier European positioning across hip, knee, and shoulder prostheses. Directly comparable in product scope, channel mix (direct + distributor), and private ownership structure.
• LimaCorporate: Italian orthopedic implant specialist (hip, knee, shoulder) acquired by Enovis; comparable in European manufacturing heritage, joint reconstruction focus, and mid-tier scale. Now part of a larger platform, illustrating one possible exit pathway.
• FH Orthopedics (now part of Olympus): French orthopedic implant manufacturer with overlapping hip, knee, shoulder, and extremity portfolios; directly competes with Groupe Lépine in the French hospital channel and on global specialty sports/extremity segments.
• Medacta International: Swiss family-owned orthopedic implant manufacturer specializing in hip, knee, shoulder, and spine, with global direct and distributor sales. Closest European privately-held peer in scale, product breadth, and innovation cadence (e.g., single-use instrumentation, patient-matched solutions).
• Mathys (Mathys AG Bettlach): Swiss orthopedic implant maker focused on hip, knee, shoulder, and orthobiologics with strong European surgeon relationships. Comparable mid-sized European specialty vendor with vertically integrated manufacturing.

Broad incumbents

• DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedic franchise, a global leader across hip, knee, shoulder, trauma, and sports medicine. Overlaps with virtually all of Groupe Lépine's product categories but operates from a vastly larger platform with unmatched global sales coverage and clinical evidence generation.
• Smith+Nephew: Global medical device company with established hip, knee, and shoulder reconstruction franchises plus sports medicine and extremities overlap. Competes in joint reconstruction with a broader portfolio and stronger US/UK commercial footprint.
• Stryker: Global orthopedic and surgical equipment major with major hip, knee, shoulder (post-Tornier/Mako acquisition), and extremities businesses. Competes across most of Groupe Lépine's product lines with substantially larger R&D, sales, and clinical evidence investment.
• B. Braun Aesculap: German-headquartered division of B. Braun Melsungen, with broad orthopedic implant and surgical instrument portfolios. Overlaps directly in hip/knee and surgical instruments but competes from a much larger corporate platform and global hospital footprint.
• Zimmer Biomet: One of the world's largest orthopedic implant manufacturers, with leading hip, knee, shoulder, and extremities franchises plus robotics, digital surgery, and biologics. Competes in the same surgical specialties but at a fundamentally larger scale and with global commercial reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/GroupeLepine

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Groupe Lépine